-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/antipsychotics-children-update_research-protocol.pdf
December 04, 2015 - Persistent depressive disorder requires
symptoms of at least one year (two in adults). … Psychotropic practice patterns for youth: a 10-year
perspective. … (year!
approved)!
Indications! Age!group!approved!for! Black!box!warnings! … (year!
approved)!
Indications! Age!group!approved!for! Black!box!warnings! … (year!
approved)!
Indications! Age!group!approved!for! Black!box!warnings!
-
effectivehealthcare.ahrq.gov/sites/default/files/obesity-horizon-scan-high-impact-1406.pdf
June 01, 2014 - health care system (e.g.,
patient outcomes, utilization, infrastructure, costs) is aggregated twice a year … This report is being generated twice a year. … The authors reported the following results:78
At 1 year, 55.4% of patients (883 of 1595) receiving … At 1 year, 47.5% of patients in the lorcaserin group and
20.3% in the placebo group had lost 5% or … year 2 (67.9%) than in patients who received placebo during year 2 (50.3%,
P<0.001).
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/prosthesis_research-protocol.pdf
March 16, 2017 - increased risk for cardiovascular disease,3 anxiety,
and depression4) and higher mortality (estimated 5-year … mortality rates for amputees
range between 50%5 and 74%6; estimated 1-year mortality is 36% for amputees … At 6 months, 1 year, and 5 years after receipt of a LLP, (accounting for
intervening mortality, subsequent … “Projection of the year
2050 burden of diabetes in the US adult population: Dynamic modeling of incidence … A one-year national survey of patients having a
lower limb amputation.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/juvenile-arthritis-dmards_disposition-comments.pdf
September 01, 2011 - lymphoma reported by Imundo
(Imundo L, 2008, J Rheumatol
2008;35(8):1681-2) was diagnosed in a 21-
year … Patients were given the option to receive open-label
treatment with abatacept in a 5 year follow-up … Olfman, Joshua
(Amgen)
Results (Pg 36) Table 4 includes the 2-year (Lovell, Giannini, Reiff, et al … (Lovell, Reiff,
Jones, et al., 2006) or 8-year (Lovell, Reiff, Ilowite, et al., 2008 follow-
up. … Amgen requests that the following sentence be added: “This trial
included an 8-year extension, during
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/cancer-end-of-life-quality-meaures_research.pdf
April 01, 2010 - Research Report Number 21
1
Introduction
While cancer causes more than a half million deaths each year … probability of death with logistic regression models using baseline characteristics
including age (5-year … adjusted for age, gender, race, income,
primary site of cancer, Charlson score, cancer stage, and year … Hospice
usage by minorities in the last year of life:
results from the National Mortality
Followback … Patient Model were: age, gender, race, income, primary site of cancer, Charlson score, cancer stage, year
-
effectivehealthcare.ahrq.gov/sites/default/files/pregnancy-horizon-scan-high-impact-1412.pdf
December 01, 2014 - health care system (e.g.,
patient outcomes, utilization, infrastructure, costs) is aggregated twice a year … This report is being generated twice a year.
-
effectivehealthcare.ahrq.gov/sites/default/files/developmental-delays-horizon-scan-high-impact-1506.pdf
December 01, 2015 - health care system (e.g.,
patient outcomes, utilization, infrastructure, costs) is aggregated twice a year … This report is being generated twice a year.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/liver-cancer_research-protocol.pdf
July 24, 2013 - bile duct cancer is 1 in
132, with the age-adjusted incidence rate being 7.3 per 100,000 people per year … The age-adjusted death rate is estimated at 5.2 per 100,000 people per year in the
United States, with … The overall 5-year
relative survival rate is 14.4 percent. … The 2011 Annual Report to the Nation on the Status of Cancer reported that for the 5-year
and 10-year … Global cancer statistics in the year 2000. Lancet Oncol. 2001 Sep;2(9):533-43.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/infantile-hemangioma_clinician.pdf
June 01, 2016 - Management of Infantile Hemangioma
Management of Infantile Hemangioma
Background
Infantile hemangioma (IH) is the most common tumor of
childhood and is estimated to affect about 4 to 5 percent of
children, with higher prevalence in premature infants and
in whites. IH tends to go through growth and involution
ph…
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/suicide-prevention_research-protocol.pdf
December 23, 2015 - to 12 per 100,000.1, 2 In 2013 suicide was the second leading
cause of death among 15-19 and 20-29 year … Includes:
• enrolled in school at some time during the school year;
• expected to be in membership … the following school year; and,
• not enrolled in grades 9–12 in by October 1 of the following year … Does not include:
• reported as a dropout in the year before;
• among students who graduated high … stopped
• Planned
o Year planned
§ Data collection’s [anticipated] starting date/year
o Validity
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/white-paper-framework-for-conceptualizing-evidence-needs_0.pdf
December 01, 2017 - The number of products created annually by each center varied widely, from over 300
products a year … and KPSC that performed rapid reviews and served a
large number of hospitals, to approximately 30 a year … for Penn CEP, which performs rapid
10
reviews but serves fewer hospitals, to less than 20 a year … ; ECRI HTAIS, ECRI Institute Health Technology Assessment Information Service; FY, fiscal year; GRADE … C-6
First Author, Year Setting Findings
Gifford 201442 Canada Evaluation of organizational
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/glaucoma-treatment_disposition-comments.pdf
April 01, 2012 - We considered all studies and the 1 year term was a
MINIMUM for certain categories. … Three-year follow-up of the tube versus trabeculectomy study. … from the pivotal
Advanced Glaucoma Intervention Study (all 14 papers) (AGIS)
and from the recent 3-year … (Five-year
follow-up optic disc findings of the Collaborative Initial Glaucoma
Treatment Study. … For example, individual treated with
numerous medications for a 10 year period of time, followed by
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/allergy-seasonal_research-protocol.pdf
March 08, 2012 - clinical trials of at least 300 patients evaluated for 6 months or 100 patients
evaluated for at least 1 year … Some
anticipated elements include, but are not limited to, the following: author, study year, enrollment
-
effectivehealthcare.ahrq.gov/sites/default/files/therapies-for-autism-spectrum-disorder-2-9-2010.pdf
January 01, 2010 - table will
vary by key question, but the tables will contain some common elements, such as author, year … Autism and Developmental Disabilities Monitoring Network Surveillance Year 2002
Principal Investigators
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/autism_research-protocol.pdf
December 09, 2009 - table will
vary by key question, but the tables will contain some common elements, such as author, year … Autism and Developmental Disabilities Monitoring Network Surveillance Year 2002
Principal Investigators
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND_0210_12-07-2009.pdf
January 01, 2009 - )
In the United States, approximately 1.5 million traumatic brain injuries occur per year.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND_0351_05-10-2010.pdf
January 01, 2010 - infants initially affected by cryptorchidism have
testes that spontaneously descend within the first year
-
effectivehealthcare.ahrq.gov/sites/default/files/peptic-ulcer-horizon-scan-high-impact-1312.pdf
December 01, 2013 - This report is being generated twice a year. … enroll at least 200 new patients in at least 20 to 25 centers in the United
States and conduct 5-year … , an estimate based on data from the early 1990s, at a cost
of more than $100,000 per patient per year … The most frequent adverse event was dysphagia (in 68% of patients
postoperatively, in 11% at 1 year … six patients the device was removed.”11
In 2012, Lipham and colleagues published results from a 4-year
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/omega-3-maternity_disposition-comments.pdf
October 12, 2016 - The Almaas article is a 7-year
followup to the study first reported by
Westerberg and Henriksen: we … Four-year follow-up of
children born to women in a randomized trial of
prenatal DHA supplementation … Maternal fish oil supplementation in pregnancy: a 12
year follow-up of a randomised controlled trial … Customarily, update
searches commence with the publication
year one year prior to the latest search … For this
review, we actually went back to the year
2000, 4 years prior to the original
searches.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-196-evidence-summary-immunotherapy-asthma.pdf
March 01, 2018 - A 1-year, placebo-
controlled, double-blind house-dust-mite immunotherapy study in
asthmatic adults. … Efficacy analysis of three-year
subcutaneous SQ-standardized specific immunotherapy in house
dust mite-allergic … immunotherapy with a standardized Dermatophagoides
pteronyssinus extract in asthmatic children: a three-year … Anaphylactic shock because of sublingual
immunotherapy overdose during third year of maintenance
dose